Skip to main content
OpenTrials

Clinical trial condition

Peripheral T Cell Lymphoma

Explore clinical trials studying Peripheral T Cell Lymphoma. Study availability and eligibility vary by location and protocol.

52 public trials 24 recruiting studies
Refine in advanced search Browse all conditions

Peripheral T Cell Lymphoma trial results

Completed

Minimal Residual Disease in Peripheral T-cell Lymphoma

NCT03297697

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Completed

Safety and Efficacy of Lacutamab in Patients With Relapsed/Refractory Peripheral T-cell Lymphoma That Express KIR3DL2

NCT05321147

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • University of Alabama at Birmingham- O'Neal Comprehensive Cancer Center Birmingham, Alabama, United States
  • University of California at Irvine - Chao Family Comprehensive Cancer Center Orange, California, United States
  • Goshen Health- Goshen Hospital Goshen, Indiana, United States
  • Indiana University School of Medicine Indianapolis, Indiana, United States
View all 20 locations
View Trial Details
Completed

Evaluation of the Combination of Romidepsin and Carfilzomib in Relapsed/Refractory Peripheral T Cell Lymphoma Patients

NCT03141203

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Queen Elizabeth Hospital Birmingham, United Kingdom
  • St James's University Hospital Leeds, United Kingdom
  • Leicester Royal Infirmary Leicester, United Kingdom
  • Clatterbridge Cancer Centre Liverpool, United Kingdom
View all 13 locations
View Trial Details
Completed

Depsipeptide to Treat Patients With Cutaneous T-Cell Lymphoma and Peripheral T-Cell Lymphoma

NCT00007345

Conditions
Cutaneous T Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • University of Arkansas Little Rock, Arkansas, United States
  • City of Hope National Cancer Center Duarte, California, United States
  • Mercy General Hospital Sacramento, California, United States
View all 13 locations
View Trial Details
Active, Not Recruiting

Study of Lacutamab in Peripheral T-cell Lymphoma

NCT04984837

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations
  • Institut Jules Bordet Anderlecht, Belgium
  • VZW ZAS Antwerp, Belgium
  • A. Z. Sint-Jan Bruges, Belgium
  • Cliniques Universitaires de Bruxelles - Hôpital Erasme Brussels, Belgium
View all 64 locations
View Trial Details

Related conditions